Article Text

PDF
Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout
  1. Ole Slot
  1. Correspondence to Dr Ole Slot, Department of Rheumatology, Copenhagen University Hospital Glostrup, Ndr. Ringvej, Glostrup DK-2600, Denmark; ole.slot.01{at}regionh.dk

Statistics from Altmetric.com

Homocysteine (Hcy) is an amino acid formed by demethylation of methionine. Impaired renal function, enzymatic polymorphisms, and low levels of B-group vitamins dispose to hyperhomocysteinaemia (HHcy).1 ,2 HHcy as well as hyperurecaemia induce reactive oxygen species and impair endothelial function1 ,3 and are associated with increased risk of cardiovascular disease (CVD).1–4 Hcy and urate possibly have additive effects on the endothelial function.5

Studies in normal populations have shown positive correlations between p-Hcy and p-urate,6 ,7 but reports on the prevalence of HHcy in gout patients have shown conflicting results.8–10

To study the prevalence of HHcy in gout—133 …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.